Loading the company…
Loading the company…
Families: Skin substitutes & wound grafts.
All companies · Product and company coverage
In the last ten years FDA made 1 decision for Covalon Technologies (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2026 (1). The latest was on 2026-09-09.
| Family | Decisions on record |
|---|---|
| Skin substitutes & wound grafts | 4 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-09 | 510(k) | K260652 | ColActive Plus |
| 2013-08-16 | 510(k) | K123756 | COVAGEN |
| 2006-04-18 | 510(k) | K060804 | COLLAGRAN-COLLAGEN WOUND DRESSING, COLLAGRANAG-COLLAGEN W/SILVER ANTIMICROBIAL WOUND DRESSING |
| 2006-02-03 | 510(k) | K052696 | COVACLEARAG COLLAGEN WITH SILVER ANTIMICROBIAL GEL SHEET DRESSING |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Covalon Technologies.